104 related articles for article (PubMed ID: 8949417)
1. [Tertiary hyperparathyroidism induced by the treatment of hypophosphatemic osteomalacia].
Vedere V; Goupille P; Valat JP; Lecomte P
Ann Endocrinol (Paris); 1996; 57(3):215-8. PubMed ID: 8949417
[TBL] [Abstract][Full Text] [Related]
2. Development of hypercalcemic hyperparathyroidism after long-term phosphate supplementation in hypophosphatemic osteomalacia. Report of two cases.
Firth RG; Grant CS; Riggs BL
Am J Med; 1985 Apr; 78(4):669-73. PubMed ID: 2984933
[TBL] [Abstract][Full Text] [Related]
3. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the parathyroid function in six patients with hypophosphatemic osteomalacia, including a case of tertiary hyperparathyroidism developing during combined oral phosphate and vitamin D therapy.
Jeon HJ; Kwon SH; Kim SW; Shin CS; Park KS; Kim SY; Cho BY; Lee HK
Horm Res; 2003; 60(3):127-33. PubMed ID: 12931040
[TBL] [Abstract][Full Text] [Related]
5. Tumor-induced hypophosphatemic osteomalacia associated with tertiary hyperparathyroidism: a case report.
Tartaglia F; Minisola S; Sgueglia M; Blasi S; Brunelli D; Degli Effetti E; Maturo A; Cola A; Custureri F; Campana FP
G Chir; 2006; 27(1-2):9-13. PubMed ID: 16608626
[TBL] [Abstract][Full Text] [Related]
6. Development of tertiary hyperparathyroidism after phosphate supplementation in oncogenic osteomalacia.
Huang QL; Feig DS; Blackstein ME
J Endocrinol Invest; 2000 Apr; 23(4):263-7. PubMed ID: 10853715
[TBL] [Abstract][Full Text] [Related]
7. Tertiary hyperparathyroidism after long-term phosphate supplementation in adult-onset hypophosphataemic osteomalacia.
Narváez J; Rodriguez-Moreno J; Moragues C; Campoy E; Clavaguera T; Roig-Escofet D
Br J Rheumatol; 1996 Jun; 35(6):598-600. PubMed ID: 8670586
[TBL] [Abstract][Full Text] [Related]
8. The efficacy of vitamin D2 and oral phosphorus therapy in X-linked hypophosphatemic rickets and osteomalacia.
Lyles KW; Harrelson JM; Drezner MK
J Clin Endocrinol Metab; 1982 Feb; 54(2):307-15. PubMed ID: 6976353
[No Abstract] [Full Text] [Related]
9. 24,25-Dihydroxycholecalciferol treatment of osteomalacia: use in a patient with vitamin D deficiency and hyperparathyroidism.
Silver J; Zimmerman J; Sela J; Rubinger D; Friedlaender MM; Popovtzer MM
Isr J Med Sci; 1984 May; 20(5):437-9. PubMed ID: 6332095
[No Abstract] [Full Text] [Related]
10. Tertiary hyperparathyroidism after high-dose phosphate therapy in adult-onset hypophosphatemic osteomalacia.
Younis E; Jarrah N; Sroujieh AS; Al Hadidy A; Ajlouni K
Endocr Pract; 2001; 7(5):375-8. PubMed ID: 11585374
[TBL] [Abstract][Full Text] [Related]
11. [Hyperparathyroidism associated with hypophosphatemic osteomalacia: case report and review of the literature].
Moreira RO; Leal CT; Lacativa PG; Figueiredo JG; Lima MB; Farias ML
Arq Bras Endocrinol Metabol; 2006 Feb; 50(1):150-5. PubMed ID: 16628288
[TBL] [Abstract][Full Text] [Related]
12. [Hypophosphatemic vitamin D resistant osteomalacia with parathyroid adenoma (author's transl)].
Blanc D; Mouries D; Phelip X
Sem Hop; 1980 Jan 18-25; 56(3-4):184-7. PubMed ID: 6244654
[TBL] [Abstract][Full Text] [Related]
13. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
Lorenzo Sellares V; Torregrosa V
Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742
[TBL] [Abstract][Full Text] [Related]
14. Healing of bone lesions with 1,25-dihydroxyvitamin D3 in the young X-linked hypophosphatemic male mouse.
Marie PJ; Travers R; Glorieux FH
Endocrinology; 1982 Sep; 111(3):904-11. PubMed ID: 6896684
[TBL] [Abstract][Full Text] [Related]
15. Vitamin D resistant hypophosphatemic osteomalacia associated with osteosarcoma of the mandible: report of a case.
Nomura G; Koshino Y; Morimoto H; Kida H; Nomura S; Tamai K
Jpn J Med; 1982 Jan; 21(1):35-9. PubMed ID: 6279944
[TBL] [Abstract][Full Text] [Related]
16. Hyperparathyroidism and 1,25-dihydroxyvitamin D deficiency in mild, moderate, and severe renal failure.
Pitts TO; Piraino BH; Mitro R; Chen TC; Segre GV; Greenberg A; Puschett JB
J Clin Endocrinol Metab; 1988 Nov; 67(5):876-81. PubMed ID: 3182962
[TBL] [Abstract][Full Text] [Related]
17. Tumor-induced osteomalacia: the importance of measuring serum phosphorus levels.
Halperin F; Anderson RJ; Mulder JE
Nat Clin Pract Endocrinol Metab; 2007 Oct; 3(10):721-5. PubMed ID: 17893691
[TBL] [Abstract][Full Text] [Related]
18. Effects of long-term therapy with calcitriol in patients with moderate renal failure.
Healy MD; Malluche HH; Goldstein DA; Singer FR; Massry SG
Arch Intern Med; 1980 Aug; 140(8):1030-3. PubMed ID: 6893118
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of a role for 1,25-dihydroxyvitamin D3 in the pathogenesis and treatment of X-linked hypophosphatemic rickets and osteomalacia.
Drezner MK; Lyles KW; Haussler MR; Harrelson JM
J Clin Invest; 1980 Nov; 66(5):1020-32. PubMed ID: 6253520
[TBL] [Abstract][Full Text] [Related]
20. Total urinary hydroxyproline in osteomalacia and the effect upon it of treatment with vitamin D.
Smith R; Dick M
Clin Sci; 1968 Feb; 34(1):43-56. PubMed ID: 5640685
[No Abstract] [Full Text] [Related]
[Next] [New Search]
